Accendra Health Receives NYSE Notice on Market Cap and Equity Standard

Accendra Health (NYSE: ACH) said in an 8-K filed Friday, Oct. 30, that the New York Stock Exchange notified it on Oct. 27 that it is not in compliance with NYSE continued listing standards.

The rule is Section 802.01B of the NYSE Listed Company Manual. It requires an average market capitalization of at least $50.0 million over a consecutive 30 trading-day period, and stockholders' equity of at least $50.0 million. The filing does not say which of these requirements the company failed to meet.

The notice does not result in immediate delisting. The Class A Common Stock will continue to be listed and trade on the NYSE, subject to the company meeting the exchange's other continued listing requirements.

What comes next

The company intends to notify the NYSE within 10 business days of receiving the notice that it will submit a business plan. It has 45 calendar days from receipt of the notice to submit that plan, showing how it will regain compliance within 18 months of receipt. The NYSE will review the plan and, if accepted, will monitor progress quarterly.

The company said it intends to consider several alternatives to cure the shortfall.

Company context

Before the filing, the company's market capitalization was about $19.2 million, based on a $0.25 close on Oct. 30 and 76.9 million shares outstanding as of June 30, 2026. As of June 30, 2026, it reported $7.7 million in cash and equivalents.

The company said the notice does not affect its business operations or its reporting obligations with the SEC. It issued a press release on Oct. 30, furnished as Exhibit 99.1 to the filing.